fxs_header_sponsor_anchor

Compared to estimates, Standex (SXI) Q2 earnings: A look at key metrics

Standex International (SXI) reported $221.32 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 16.6%. EPS of $2.08 for the same period compares to $1.91 a year ago.

The reported revenue represents a surprise of +1.23% over the Zacks Consensus Estimate of $218.63 million. With the consensus EPS estimate being $2.00, the EPS surprise was +3.87%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Standex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net sales- Scientific: $19.5 million versus $18.85 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.6% change.
  • Net sales- Specialty solutions: $19.79 million compared to the $22.1 million average estimate based on two analysts. The reported number represents a change of -7.2% year over year.
  • Net sales- Electronics: $115.67 million versus the two-analyst average estimate of $112.05 million. The reported number represents a year-over-year change of +20.6%.
  • Net Sales- Engraving: $35.73 million versus $32.4 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.
  • Net Sales- Engineered technologies: $30.64 million versus the two-analyst average estimate of $32.55 million. The reported number represents a year-over-year change of +35.3%.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2025 FOREXSTREET S.L., All rights reserved.